FIELD: medicine.
SUBSTANCE: agent contains a nanocomposite representing carbon-containing nanoparticles coated with organic alkyl functional groups presenting radicals -C4H9, -C6H11, -C8H15, -C10H21, -C16H33, -C18H35. The above groups are applied by covalent modification with using diazonium salts of the general formula XC6H4N2+ -Y, wherein X is an alkyl radical C4H9, -C6H11, -C8H15, -C10H21, -C16H33 or C18H35, Y-anion -HSO4, -Cl, -BF4 or -OTs.
EFFECT: reducing blood plasma cholesterol and triglycerides effectively.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF IMMOBILISING BIOMOLECULES ON SURFACE OF MAGNETICALLY CONTROLLED IRON NANOPARTICLES COATED WITH CARBON COATING | 2012 |
|
RU2515197C1 |
| SYNTHESIS OF ZERO-VALENCE TRANSITION METAL NANOPARTICLES WITH SURFACE COVALENTLY MODIFIED WITH ORGANIC FUNCTIONAL GROUPS | 2014 |
|
RU2584288C2 |
| METHOD OF FUNCTIONALISING NANOPOWDER | 2008 |
|
RU2405655C2 |
| METHOD OF TREATING GASTRIC ULCER DISEASE | 2007 |
|
RU2354373C1 |
| COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES | 2006 |
|
RU2428973C2 |
| DERIVATIVES OF DIALKYL ETHER, (PHARMACEUTICAL COMPOSITION) | 1996 |
|
RU2191772C2 |
| METHOD OF ISOLATION OF PHYTOSTEROL COMPOSITION, COMPOSITIONS, THERAPEUTIC PRODUCT | 1995 |
|
RU2165431C2 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF ANTIRETROVIRAL THERAPY FOR CO-INFECTION WITH TUBERCULOSIS AND HIV INFECTION | 2017 |
|
RU2666223C1 |
| PHOSPHOLIPID THERAPEUTIC COMPOSITION WITH NANO-SIZED PARTICLES FOR LIPID STORAGE DISEASE AND COMATOSE STATES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448715C1 |
| DIAGNOSTIC TECHNIQUE FOR HIV INFECTION STAGES | 2019 |
|
RU2706548C1 |
